Profile for European Patent Office Patent: 0513200
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Luxembourg | 91073 | ⤷ Start Trial |
| Netherlands | 300148 | ⤷ Start Trial |
| United Kingdom | SPC/GB04/016 | ⤷ Start Trial |
| Austria | SZ 7/2004 | ⤷ Start Trial |
| Switzerland | C00513200/01 | ⤷ Start Trial |
| Austria | 7/2004 | ⤷ Start Trial |
| Germany | 122004000015 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 0513200
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
